Product NDC: | 55390-113 |
Proprietary Name: | Phentolamine Mesylate |
Non Proprietary Name: | Phentolamine Mesylate |
Active Ingredient(s): | 5 mg/mL & nbsp; Phentolamine Mesylate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-113 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040235 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980515 |
Package NDC: | 55390-113-01 |
Package Description: | 1 VIAL in 1 BOX (55390-113-01) > 1 mL in 1 VIAL |
NDC Code | 55390-113-01 |
Proprietary Name | Phentolamine Mesylate |
Package Description | 1 VIAL in 1 BOX (55390-113-01) > 1 mL in 1 VIAL |
Product NDC | 55390-113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phentolamine Mesylate |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19980515 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | PHENTOLAMINE MESYLATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |